Trials / Completed
CompletedNCT05974397
Nationwide Trends in Incidence, Healthcare Utilization, and Mortality in Hospitalized Acute Myocardial Infarction Patients in Taiwan
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 124,018 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This was a retrospective study using the Taiwan's National Health Insurance Research Database (NHIRD). The study employed two study designs for different purposes as follows: * A cross-sectional analysis was conducted to explore the annual incidence trends. * A longitudinal cohort study was conducted to assess baseline characteristics, treatment patterns, long-term healthcare utilization, and cause-specific mortality among incident AMI patients. In each part, the study was conducted for AMI, and separately for ST-segment elevation and non-ST- segment elevation myocardial infarction (STEMI and NSTEMI)
Conditions
Timeline
- Start date
- 2021-09-30
- Primary completion
- 2022-07-22
- Completion
- 2022-07-22
- First posted
- 2023-08-03
- Last updated
- 2023-08-03
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05974397. Inclusion in this directory is not an endorsement.